Moberg Pharma AB (publ) (STO: MOB)
Sweden
· Delayed Price · Currency is SEK 32.10
+0.38 (1.20%)
Aug 30, 2024, 5:29 PM CET
Moberg Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 38.85 | 36.92 | 116.69 | 19.38 | 16.61 | 11.71 | Upgrade
|
| Depreciation & Amortization | 16.35 | 16.01 | 16.79 | 12.4 | 7.85 | 5.69 | Upgrade
|
| Other Operating Activities | -6.2 | -3.95 | -1.69 | - | 0.3 | 0.49 | Upgrade
|
| Change in Accounts Receivable | -327.83 | -293.88 | -74.03 | -17.53 | -12.73 | 8.9 | Upgrade
|
| Change in Inventory | 215.54 | 179.4 | -344.93 | -17.39 | -7.97 | 2.94 | Upgrade
|
| Change in Other Net Operating Assets | 84.19 | 81.14 | 22.21 | -17.47 | -85.63 | 24.26 | Upgrade
|
| Operating Cash Flow | 20.91 | 15.64 | -264.96 | -20.61 | -81.57 | 53.98 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | 1518.59% | Upgrade
|
| Capital Expenditures | -93.92 | -124.93 | -41.27 | -426.32 | -134.53 | -206.38 | Upgrade
|
| Sale of Property, Plant & Equipment | 17.83 | 9.32 | 518.51 | 14.81 | 20.33 | 76.92 | Upgrade
|
| Investment in Securities | -28.91 | -28.91 | -14.84 | -4.85 | -196.04 | - | Upgrade
|
| Other Investing Activities | -18.51 | -18.51 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -123.51 | -163.02 | 462.4 | -416.35 | -310.24 | -129.46 | Upgrade
|
| Long-Term Debt Issued | - | 260 | 5 | 35 | 98.59 | 94.87 | Upgrade
|
| Long-Term Debt Repaid | - | -11.32 | -89.78 | -52.49 | -98.49 | -11.86 | Upgrade
|
| Net Debt Issued (Repaid) | 212.21 | 248.68 | -84.78 | -17.49 | 0.11 | 83.01 | Upgrade
|
| Issuance of Common Stock | - | - | - | 550.66 | 385.19 | 40 | Upgrade
|
| Common Dividends Paid | -183.39 | -165.18 | - | - | - | -5.57 | Upgrade
|
| Other Financing Activities | -0 | 0.01 | - | -11.66 | -13.27 | -2.97 | Upgrade
|
| Financing Cash Flow | 28.82 | 83.51 | -84.78 | 521.51 | 372.03 | 114.47 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | -73.78 | -63.88 | 112.66 | 84.54 | -19.79 | 38.99 | Upgrade
|
| Free Cash Flow | -73.01 | -109.29 | -306.23 | -446.93 | -216.1 | -152.4 | Upgrade
|
| Free Cash Flow Margin | -42.10% | -65.71% | -211.13% | -315.07% | -133.03% | -121.26% | Upgrade
|
| Free Cash Flow Per Share | -0.92 | -1.38 | -3.87 | -6.00 | -4.86 | -5.23 | Upgrade
|
| Cash Interest Paid | 29 | 22.47 | 7.12 | 5.99 | 8.73 | 7.01 | Upgrade
|
| Cash Income Tax Paid | 1.9 | 1.72 | 0.41 | 0.61 | 3.43 | 0.57 | Upgrade
|
| Levered Free Cash Flow | 182.42 | -134.54 | -350.04 | -434.85 | -223.15 | -107.59 | Upgrade
|
| Unlevered Free Cash Flow | 198.91 | -122.13 | -345.59 | -431.11 | -217.72 | -103.25 | Upgrade
|
| Change in Net Working Capital | -251.74 | 37.55 | 396.75 | 33.15 | 108.57 | -85.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.